aaavl2821

7 ms·

31.
Who is still investing in biotech startups?(baybridgebio.com)
2 points by aaavl2821 4y ago|0 comments
32.
Biotech's New Normal(baybridgebio.com)
2 points by aaavl2821 4y ago|0 comments
33.
The Biotech M&a Gap(baybridgebio.com)
1 points by aaavl2821 4y ago|0 comments
34.
Who Will Save Biotech?(baybridgebio.com)
1 points by aaavl2821 4y ago|0 comments
35.
Biotech VC funding down 60% in March(baybridgebio.com)
2 points by aaavl2821 5y ago|0 comments
36.
Biotech investors are slashing exposure to IPOs(baybridgebio.com)
1 points by aaavl2821 5y ago|0 comments
37.
Big investors slashing exposure to early-stage biotech stocks(baybridgebio.com)
2 points by aaavl2821 5y ago|0 comments
38.
Biotech from Bust to Boom(baybridgebio.com)
1 points by aaavl2821 5y ago|0 comments
39.
Biotech from Bust to Boom(baybridgebio.com)
1 points by aaavl2821 5y ago|0 comments
40.
Case study in analyzing clinical trial risk [video](youtube.com)
1 points by aaavl2821 5y ago|0 comments
41.
A framework for analyzing biotech clinical trial risk [video](youtube.com)
1 points by aaavl2821 5y ago|0 comments
42.
The Biotech IPO Crunch(baybridgebio.com)
2 points by aaavl2821 5y ago|0 comments
43.
Was FDA's review of aducanumab biased? [video](youtube.com)
1 points by aaavl2821 5y ago|0 comments
44.
Valuations of biotech startups from Series A to IPO(baybridgebio.com)
1 points by aaavl2821 5y ago|0 comments
45.
Analyzing clinical data of a controversial Alzheimer's drug [video](youtube.com)
2 points by aaavl2821 5y ago|0 comments
46.
Intro to interpreting clinical data for biotech investing [video](youtube.com)
1 points by aaavl2821 5y ago|0 comments
47.
Intro to Biotech DCF Analysis [video](youtube.com)
2 points by aaavl2821 5y ago|0 comments
48.
Intro to Valuation in Biotech [video](youtube.com)
2 points by aaavl2821 5y ago|0 comments
49.
The VC power law: biotech vs. tech(baybridgebio.com)
2 points by aaavl2821 5y ago|0 comments
50.
Biotech investing basics: measuring value(youtube.com)
1 points by aaavl2821 5y ago|0 comments
51.
The VC power law: tech vs. biotech(baybridgebio.com)
1 points by aaavl2821 5y ago|0 comments
52.
Biotech investing basics: value creation in biotech [video](youtube.com)
2 points by aaavl2821 5y ago|0 comments
53.
Expected returns for biotech venture investments(baybridgebio.com)
1 points by aaavl2821 5y ago|0 comments
54.
Expected returns for biotech venture investments(baybridgebio.com)
2 points by aaavl2821 5y ago|0 comments
55.
The new generation of biotech seed funds(baybridgebio.com)
2 points by aaavl2821 6y ago|0 comments
56.
Biotech Seed Investors(baybridgebio.com)
1 points by aaavl2821 6y ago|0 comments
57.
Biotech startup analysis: Korro's mRNA editing and Graphite's gene editing(baybridgebio.com)
1 points by aaavl2821 6y ago|0 comments
58.
Fighting “Eroom's Law” [video](youtube.com)
3 points by aaavl2821 6y ago|0 comments
59.
Finding ideas for biotech startups [video](youtu.be)
2 points by aaavl2821 6y ago|0 comments
60.
Interview with Max Altman, co-founder of Apollo [video](youtu.be)
1 points by aaavl2821 6y ago|0 comments

More ›